Coherus BioSciences Inc
NASDAQ:CHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
M
|
Maybank Securities Thailand PCL
SET:MST
|
TH |
|
S
|
Sabuy Connext Tech PCL
SET:SBNEXT
|
TH |
|
B
|
BW Ideol AS
OSE:BWIDL
|
NO |
|
Treasury Wine Estates Ltd
ASX:TWE
|
AU |
|
Societe Generale SA
PAR:GLE
|
FR |
|
SICO Saudi REIT Fund
SAU:4337
|
SA |
|
SOPerior Fertilizer Corp
OTC:POTRF
|
CA |
|
Biotron Ltd
ASX:BIT
|
AU |
|
Greenwing Resources Ltd
ASX:GW1
|
AU |
|
A
|
Amosense Co Ltd
KOSDAQ:357580
|
KR |
Wall Street
Price Targets
CHRS Price Targets Summary
Coherus BioSciences Inc
According to Wall Street analysts, the average 1-year price target for
CHRS
is 5.78 USD
with a low forecast of 4.04 USD and a high forecast of 7.35 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CHRS's stock price target?
Price Target
5.78
USD
According to Wall Street analysts, the average 1-year price target for
CHRS
is 5.78 USD
with a low forecast of 4.04 USD and a high forecast of 7.35 USD.
What is Coherus BioSciences Inc's Revenue forecast?
Projected CAGR
65%
For the last 12 years the
compound annual growth rate for
Coherus BioSciences Inc's revenue is
25%.
The projected
CAGR
for the next 3 years is
65%.
